Press releases | WebDisclosure

Basculer en Français

11299	Companies
251108	Keywords
180070	Articles
136947	Press releases

Home
Press releases

PRESS RELEASE

published on 09/11/2025 at 07:00, 1 year 1 month ago

NAGRAVISION Launches OpenTV® ENTera, the Next-Generation Digital Services Solution, in AWS Marketplace
NAGRAVISION launches OpenTV ENTera, a next-gen digital services solution, on AWS Marketplace, empowering operators with premium streaming experiences and new revenue opportunities

Digital Services Streaming AWS Marketplace NAGRAVISION OpenTV ENTera
PRESS RELEASE

published on 09/11/2025 at 07:00, 1 year 1 month ago

Nebius Group announces pricing of upsized private offering of $2.75 billion of convertible senior notes
Nebius Group prices $2.75 billion convertible senior notes private offering, plans to use proceeds for business growth. Also announces $1 billion Class A shares public offering. Offering upsized from $2.0 billion. Details in the press release

Business Growth Pricing Senior Notes Private Offering Nebius Group
PRESS RELEASE

published on 09/11/2025 at 07:00, 1 year 1 month ago

Nebius Group announces pricing of $1 billion public offering of Class A ordinary shares
Nebius Group prices $1 billion public offering of Class A ordinary shares along with $2,750 million convertible senior notes. Offerings aim to finance business growth and infrastructure expansion

Business Growth Public Offering Nebius Group Convertible Senior Notes Class A Ordinary Shares
REGULATED PRESS RELEASE

published on 09/11/2025 at 07:00, 1 year 1 month ago

Biophytis dévoile sa stratégie d’essai de phase 3 dans la sarcopénie avec BIO101 en Europe et en Asie
Biophytis annonce sa stratégie d'essai de phase 3 pour la sarcopénie avec BIO101 en Europe et en Asie, ciblant un marché médical important et non satisfait

Biophytis Europe Asie Sarcopénie Phase 3
REGULATED PRESS RELEASE

published on 09/11/2025 at 07:00, 1 year 1 month ago

Biophytis unveils Phase 3 Sarcopenia Trial Strategy with BIO101 in Europe and Asia
Biophytis announces Phase 3 Sarcopenia Trial Strategy with BIO101 targeting age-related sarcopenia in Europe and Asia, aiming to address a significant unmet medical need and commercial market

Biophytis Clinical Trial Sarcopenia Phase 3 BIO101
PRESS RELEASE

published on 09/11/2025 at 07:00, 1 year 1 month ago

Technip Energies to acquire Ecovyst’s Advanced Materials & Catalysts business
Technip Energies to acquire Ecovyst’s Advanced Materials & Catalysts business for US$556 million, expanding catalyst capabilities and enhancing technology offering

Acquisition Technip Energies Catalysts Ecovyst Advanced Materials & Catalysts
PRESS RELEASE

published on 09/11/2025 at 07:00, 1 year 1 month ago

Communiqué de presse : Le SAR402663 de Sanofi a obtenu la désignation « fast track » aux États-Unis pour le traitement de la dégénérescence maculaire liée à l’âge néovasculaire
Sanofi obtient la dÃ©signation 'fast track' pour le traitement de la DMLA nÃ©ovasculaire aux Etats-Unis. ThÃ©rapie gÃ©nique innovante pour rÃ©duire la perte de vision

Sanofi DÃ©signation Fast Track DMLA NÃ©ovasculaire ThÃ©rapie GÃ©nique Perte De Vision
PRESS RELEASE

published on 09/11/2025 at 07:00, 1 year 1 month ago

Technip Energies acquiert l’activité Advanced Materials & Catalysts d’Ecovyst
Technip Energies acquiert l'activité Advanced Materials & Catalysts d'Ecovyst pour 556 millions de dollars, renforçant ses capacités en catalyseurs et en technologies de procédés

Acquisition Technip Energies Ecovyst Catalyseurs Advanced Materials & Catalysts
PRESS RELEASE

published on 09/11/2025 at 06:59, 1 year 1 month ago

Biophytis dévoile sa stratégie d’essai de phase 3 dans la sarcopénie avec BIO101 en Europe et en Asie
Biophytis présente sa stratégie d'essai de phase 3 pour la sarcopénie avec BIO101 en Europe et Asie, visant à devenir pionnier dans ce domaine thérapeutique en croissance rapide

Biophytis Essai Clinique Sarcopénie Phase 3 BIO101
PRESS RELEASE

published on 09/11/2025 at 06:30, 1 year 1 month ago

R&S Group with good operating performance in H1 2025
R&S Group Holding AG reports strong H1 2025 results: EBIT CHF 40.2M, net profit CHF 28.8M, order backlog CHF 305.7M. CEO emphasizes growth strategy execution

EBIT R&S Group Holding AG Order Backlog Net Profit H1 2025 Results

Accesswire

Published on 11/09/2026 at 15:00, 38 minutes ago

Shelfietech Launched New Retail Software Platform
Published on 11/09/2026 at 14:30, 1 hour 8 minutes ago

Boron One Applies for New Exploration Licence
Published on 11/09/2026 at 14:15, 1 hour 23 minutes ago

Jericho Energy Ventures to Participate in Cantor Convergence 4th Annual Crypto and AI Infrastructure Conference
Published on 11/09/2026 at 14:00, 1 hour 38 minutes ago

Tectonic Metals Adds Mine Development and Alaska Native Partnership Leaders Ahead of 2027 Mineral Resource Estimate and Preliminary Economic Assessment
Published on 11/09/2026 at 13:35, 2 hours 3 minutes ago

Gabriel Provides Corporate Update

View all ACCESSWIRE

EQS Group

Published on 11/09/2026 at 15:25, 13 minutes ago

EcoGraf Appoints Volkmar Klein as Strategic Advisor to the Board
Published on 11/09/2026 at 15:05, 32 minutes ago

DIVEROID's WatchDive Turns Everyday Smartwatches into Dive Computers, Launching on Kickstarter in December
Published on 11/09/2026 at 15:05, 32 minutes ago

Harley-Davidson Selects Horizon Global as Growth Partner
Published on 11/09/2026 at 15:00, 38 minutes ago

PhotonPay Strengthens North American Regulatory Footprint with Canada's RPAA Registration
Published on 11/09/2026 at 14:55, 43 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

Les Echos

Published on 11/09/2026 at 14:31, 1 hour 7 minutes ago

261109 BENETEAU Transactions sur actions propres
Published on 11/09/2026 at 10:32, 5 hours 6 minutes ago

Disclosure of shares outstanding and voting rights - 09.11.2026
Published on 11/09/2026 at 10:32, 5 hours 6 minutes ago

Déclaration nombre d'actions et droits de vote - 09.11.2026
Published on 11/09/2026 at 07:00, 8 hours 38 minutes ago

bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 8 hours 38 minutes ago

BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA

View all LES ECHOS COMFI WIRE